Luminance Health AG today announced a strategic partnership with Advyzom LLC, a Danforth Health company, to deliver transatlantic regulatory expertise for life science companies.

The collaboration combines Luminance Health’s  European regulatory expertise with Advyzom’s expertise in US regulatory strategy, scientific communication and submissions to Health Authorities for medicines, creating a transatlantic service model designed to support life science innovators from early development through regulatory approval, launch and beyond.

Luminance Health and Advyzom each bring a proven track record and highly experienced teams,  providing clients with a seamless, senior‑level advisory approach. The partnership enables companies to navigate increasingly complex global regulatory landscapes with consistent guidance, transparent communication, and harmonized development pathways.

“This strategic partnership with Advyzom enhances our ability to help our clients navigate global regulatory environments with clarity, speed, and confidence,” said Shayesteh Fürst Ladani, CEO of Luminance Health. “Our combined experience ensures that innovators have access to the strategic insight they need at every stage of development.”

“We are excited to collaborate with Luminance Health to offer clients a seamless bridge between US and European regulatory strategies,” said Cindy Dinella, CEO of Advyzom. “By leveraging our collective expertise, we can empower life science innovators to accelerate development and deliver impactful therapies to patients worldwide.”

“This partnership expands the strategic horizon for our clients,” added Nathalie Schober-Ladani, Chief Strategy Officer at Luminance Health. “Together, we bring a truly integrated global development pathway, uniting regional expertise, cross‑functional excellence, and a shared commitment to accelerating responsible innovation and better patient outcomes.”

About Luminance Health AG

Luminance Health is a premium life science consultancy offering personalized, expert support across strategic development, regulatory affairs, quality assurance, pharmacovigilance, market access, public affairs, medical communications, and compliance. The company empowers innovators to navigate complex regulatory and policy environments and to bring safe, effective, and compliant products to patients worldwide.

About Advyzom LLC, a Danforth Health Company

Advyzom LLC, a Danforth Health Company is a US‑based boutique consultancy specializing in global strategic regulatory advice from early development to post-approval life-cycle management, US Agent/FDA engagement, submissions, and strategic medical writing across a wide range of therapeutic areas and treatment modalities. Known for its senior‑level expertise and hands‑on approach, Advyzom partners with companies in designing and communicating effective development strategies that resonate with regulators and stakeholders throughout the products lifecycle to ensure each client’s asset is successfully transformed into a valuable therapy for patientsDanforth Health is a unified platform purpose-built to empower life science innovation. By integrating the capabilities of best-in-class affiliates, Danforth Health provides tailored, cross-functional support across finance and human resources, investor and public relations, discovery and development, regulatory, clinical operations, and commercialization.